Brief: Coherus Completes Strategic Transformation With Successful Divestiture Of Udenyca Franchise
14/04/2025 15:08
April 14 (Reuters) - Coherus BioSciences Inc CHRS.O: COHERUS COMPLETES STRATEGIC TRANSFORMATION WITH SUCCESSFUL DIVESTITURE OF UDENYCA® FRANCHISE Source text: ID:nGNX8LCWwR Further company coverage: CHRS.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Coherus Oncology
See all newsBrief: Coherus Oncology Initiates Process To Sell Legacy Biosim Assets
Brief: Coherus Oncology Announces Special Dividend Of Biosimilar Contingent Value Rights
Coherus Oncology Inc reports results for the quarter ended June 30 - Earnings Summary
Coherus Oncology Q2 revenue rises 40% on higher LOQTORZI volume, but slightly falls below estimates
Brief: Coherus Oncology Q2 Net Income USD -20.631 Million